Jacobs Levy Equity Management’s Inozyme Pharma INZY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-129,749	Closed	-$359K	–	1138
2024 Q4	$359K	Buy	+129,749	New	+$359K	﹤0.01%	854
2022 Q1	–	Sell	-88,921	Closed	-$606K	–	1031
2021 Q4	$606K	Buy	88,921 +67,884	+323%	+$463K	﹤0.01%	813
2021 Q3	$244K	Buy	+21,037	New	+$244K	﹤0.01%	959